Mingyong Wang
ARTS Group (China)(CN)
Publications by Year
Research Areas
Gut microbiota and health, Immune cells in cancer, Probiotics and Fermented Foods, Cervical Cancer and HPV Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Chitooligosaccharides Prevents the Development of Colitis-Associated Colorectal Cancer by Modulating the Intestinal Microbiota and Mycobiota(2019)81 cited
- → Maternal High-Fat Feeding Increases Placental Lipoprotein Lipase Activity by Reducing SIRT1 Expression in Mice(2015)70 cited
- → Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China(2022)55 cited
- → The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma(2018)34 cited
- → The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol(2023)31 cited
- → Interplay between the Gut Microbiome and Metabolism in Ulcerative Colitis Mice Treated with the Dietary Ingredient Phloretin(2021)10 cited
- → High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia(2022)9 cited
- → MBL Binding with AhR Controls Th17 Immunity in Silicosis-Associated Lung Inflammation and Fibrosis(2022)7 cited
- → High expression of CD28 enhanced the anti-cancer effect of siRNA-PD-1 through prompting the immune response of melanoma-bearing mice(2022)6 cited
- → Mannan-binding lectin ameliorates renal fibrosis by suppressing macrophage-to-myofibroblast transition(2023)6 cited